Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Retention and response rates in 14261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Nasim Ahmed Khan
  • Horace Jack Spencer
  • Elena Nikiphorou
  • Antonio Naranjo
  • Rieki Alten
  • Rodica M Chirieac
  • Alexandros A Drosos
  • Pál Géher
  • Nevsun Inanc
  • Eduardo Kerzberg
  • Codrina Mihaela Ancuta
  • Rüediger Müller
  • Lykke Ørnbjerg
  • Tuulliki Sokka
View graph of relations

Objective: To assess intercentre variability in the ACR core set measures, DAS28 based on three variables (DAS28v3) and Routine Assessment of Patient Index Data 3 in a multinational study.

Methods: Seven thousand and twenty-three patients were recruited (84 centres; 30 countries) using a standard protocol in the Quantitative Standard Monitoring of Patients with RA study. Analysis of variance (ANOVA) and mixed-effect analysis of covariance models were used to model the relationship between study centre and different patient-reported and physician-reported RA activity measures. These models were built to adjust for the remaining ACR core set measure (for each ACR core set measure or each composite index), socio-demographics and medical characteristics. ANOVA and analysis of covariance models yielded similar results, and ANOVA tables were used to present variance attributable to recruiting centre.

Results: The proportion of variances attributable to recruiting centre was lower for patient reported outcomes (PROs: pain, HAQ, patient global) compared with objective measures (joint counts, ESR, physician global) in all models. In the full model, variance in PROs attributable to recruiting centre ranged from 1.53% for patient global to 3.71% for HAQ compared with objective measures that ranged from 5.92% for physician global to 9.25% for ESR; and was lower for Routine Assessment of Patient Index Data 3 (2.6%) compared with DAS28v3 (11.75%).

Conclusion: Intercentre variability in PROs is lower than objective measures of RA activity demonstrating that PROs may be more comparable across centres, and the need for standardization of objective measures.

Original languageEnglish
JournalRheumatology (Oxford, England)
Issue number8
Pages (from-to)1395-1400
Number of pages6
Publication statusPublished - 1 Aug 2017

Bibliographical note


    Research areas

  • Analysis of Variance, Antirheumatic Agents, Arthritis, Rheumatoid, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Patient Reported Outcome Measures, Reproducibility of Results, Severity of Illness Index, Treatment Outcome, Evaluation Studies, Journal Article, Multicenter Study

ID: 52039876